Drugs & Targets Bavencio receives accelerated approval for Merkel cell carcinoma March 30, 2017Vol.40 No.03
Health Disparities Black and Hispanic women in Connecticut less likely to undergo gene expression profiling March 30, 2017Vol.40 No.03
St. Jude study reveals how an enzyme puts the brakes on aggressive disease March 30, 2017Vol.40 No.03
In phase II studies Apatorsen improved outcomes in bladder, prostate cancers March 30, 2017Vol.40 No.03
Olaparib phase III SOLO-2 trial demonstrates significant PFS benefit in BRCA-mutated disease March 30, 2017Vol.40 No.03
Carfilzomib produces OS benefit vs. bortezomib in relapsed, refractory disease March 30, 2017Vol.40 No.03
